PD Dr. Peter Fasching



Organisation


Professur für Translationale Frauenheilkunde und Geburtshilfe


Project member


BIG-THERA: Integrative 'Big Data Modeling' for the development of novel therapeutic approaches for breast cancer
Prof. Dr. Diana Dudziak
(01/01/2017 - 31/12/2019)


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 32 Go to next page Go to last page

Fejzo, M.S., Fasching, P., Schneider, M., Schwitulla, J., Beckmann, M., Schwenke, E.,... Mullin, P.M. (2019). Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support Causality. Geburtshilfe und Frauenheilkunde, 79(4), 382-388. https://dx.doi.org/10.1055/a-0830-1346
Matthies, L.M., Taran, F.-A., Keilmann, L., Schneeweiss, A., Simoes, E., Hartkopf, A.D.,... Wallwiener, M. (2019). An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study. Journal of Medical Internet Research, 21(1), e10004-. https://dx.doi.org/10.2196/10004
Mayer, I.A., Prat, A., Egle, D., Blau, S., Alejandro Perez Fidalgo, J., Gnant, M.,... Arteaga, C.L. (2019). A phase II randomized study of neoadjuvant letrozole plus alpelisib for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (NeO-ORB). Clinical Cancer Research, 25(10), 2975-2987. https://dx.doi.org/10.1158/1078-0432.CCR-18-3160
Turner, N.C., Telli, M.L., Rugo, H.S., Mailliez, A., Ettl, J., Grischke, E.-M.,... Robson, M.E. (2019). A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO). Clinical Cancer Research, 25(9), 2717-2724. https://dx.doi.org/10.1158/1078-0432.CCR-18-1891
Wunderle, M., Pretscher, J., Brucker, S.Y., Volz, B., Hartmann, A., Fiessler, C.,... Rauh, C. (2019). Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer. Breast Cancer Research and Treatment, 174(2), 453-461. https://dx.doi.org/10.1007/s10549-018-05115-6
Arkadius, P., Marie, T., Fabienne, S., Thomas, W.P.F., Brigitte, R., Andreas, H.,... Tanja, F. (2019). Circulating tumor cells in metastatic breast cancer: clinical relevance and biological potential. Current Opinion in Obstetrics & Gynecology, 31(1), 76-81. https://dx.doi.org/10.1097/GCO.0000000000000514
Denkert, C., Budczies, J., Regan, M.M., Loibl, S., Dell’Orto, P., von Minckwitz, G.,... Viale, G. (2019). Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial. Breast Cancer Research and Treatment. https://dx.doi.org/10.1007/s10549-018-05112-9
Untch, M., Loibl, S., & Fasching, P. (2019). Concerning Dediu M, Zielinski A: A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer. Breast Care 2019; Doi 10.1159/000500620. Breast Care. https://dx.doi.org/10.1159/000500624
Laakmann, E., Witzel, I., Fasching, P., Rezai, M., Schem, C., Solbach, C.,... Loibl, S. (2019). Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto. Breast Cancer Research, 21(1). https://dx.doi.org/10.1186/s13058-019-1144-x
Schneeweiss, A., Denkert, C., Fasching, P., Fremd, C., Gluz, O., Kolberg-Liedtke, C.,... Lück, H.J. (2019). Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) - Recommendations for Daily Routine Practice. Geburtshilfe und Frauenheilkunde, 79(6), 605-617. https://dx.doi.org/10.1055/a-0887-0285

Last updated on 2019-14-02 at 22:51